Skip to main content

Table 3 Analysis of recurrence patterns in the primary group

From: Efficacy and toxicity of photon, proton, and carbon ion radiotherapy in the treatment of intracranial solitary fibrous tumor/hemangiopericytoma

Patient

(sex)

Age

(years)

TTP

(months)

RT dose

(dose per fraction)

RT modality

Recurrence

Analysis of recurrence patterns in the primary group

1 (f)

24

41

60.0 (2.0)

proton

out-field

2 (f)

65

72

59.4 (1.8)

3D-conformal

out-field

3 (f)

47

225

57.6 (1.8)

3D-conformal

out-field

4 (f)

44

86

57.6 (1.8)

3D-conformal

out-field

5 (f)

63

62

55.8 (1.8)

3D-conformal

in-field

6 (f)

36

85

60.0 (2.0)

3D-conformal

in-field

7 (f)

52

91

54.0 (1.8)

3D-conformal

in-field

8 (m)

52

72

60.0 (2.0)

IMRT

in-field

9 (f)

54

38

60.0 (2.0)

IMRT

out-field

10 (f)

64

17

59.4 (1.8)

3D-conformal

in-field

11 (f)

43

89

54.0 (1.8)

3D-conformal

out-field

12 (f)

68

71

54.0 (1.8)

3D-conformal

in-field

13 (m)

39

217

59.4 (1.8)

3D-conformal

out-field

14 (m)

29

74

54.0 (1.8)

IMRT

out-field

Patient

(sex)

Age

(years)

TTP

(months)

RT dose

(dose per fraction)

RT modality

Recurrence

Analysis of recurrence patterns in the recurrence group

4 (f)

52

16

45.0 (3.0)

C12-ions

out-field

6 (f)

43

15

51.0 (3.0)

C12-ions

in-field

7 (f)

60

24

40.0 (2.0)

3D-conformal

in-field

8 (m)

59

36

51.0 (2.0)

C12-ions

in-field

9 (f)

59

9

51.0 (3.0)

C12-ions

out-field

10 (f)

65

1

51.0 (3.0)

C12-ions

out-field

13 (m)

57

29

18.0 (18.0)

Cyberknife

in-field

  1. The table shows the detailed data on the patients who suffered a relapse. Listed are age at diagnosis, time to progression, radiation dose and modality, and recurrence-pattern
  2. f = female, m = male, TTP = time to progress, RT = Radiotherapy, IMRT = Intensity modulated radiotherapy, C12-ions = Carbon ions